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To provide accurate diagnostic screening of deaf people who use signed 
communication, cognitive tests must be devised and administered in signed 
languages with normative deaf samples. This paper describes the development of 
the first screening test for detection of cognitive impairment and dementia in deaf 
signers. The British Sign Language Cognitive Screening Test (BSL-CST) uses 
standardised video administration to screen cognition using signed, rather than 
spoken or written, instructions and a large norm-referenced sample of 226 
cognitively-healthy deaf older people. Percentiles are provided for clinical 
comparison. The tests showed good reliability, content validity and correlation with 
age, intellectual ability and years of education. Clinical discrimination was shown 
between the normative sample and fourteen deaf patients with dementia. This 
innovative new testing approach transforms the ability to detect dementia in deaf 
people, avoids the difficulties of using an interpreter and enables culturally and 
linguistically sensitive assessment of deaf signers, with international potential for 
adaptation into other signed languages. 
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Introduction 
We present a new neurocognitive screening test designed to detect acquired 
cognitive impairment and dementia in deaf people who use sign language for 
communication. Prelingual deafness does not cause intellectual disability and deaf 
people show normal intelligence when assessed using appropriate nonverbal 
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performance measures except where there is an additional disability affecting 
cognition (Vernon, 2005). Until now, assessment of cognitive neurodegeneration in 
deaf individuals has been limited to tests originally developed for populations using 
spoken languages, which are not validated or normed for use with deaf signers 
(Dean, Feldman, Morere & Morton, 2009). To take one issue, these tests measure 
verbal language ability and verbal memory, with scores referenced against norms 
from the general population; these domains are known to be weak in the cognitive 
profiles of prelingually deaf people and will inevitably lack validity for deaf people 
(See Baker & Baker, 2011 for a review). There is a need for new cognitive screens 
containing verbal measures directly derived in sign languages, and norms for deaf 
populations.  
As in other countries, British Sign Language (BSL) users in the UK form a close-knit 
linguistic and cultural minority community. The use of upper-case D in Deaf signifies 
a cultural and language minority group, distinguishing them from people with 
acquired hearing loss or those who prefer to communicate using only spoken 
language. These latter groups also face barriers in obtaining reliable assessment but 
are not the focus of the study reported here. Sign languages are morphologically 
complex and grammatically unrelated to the spoken languages which surround them 
(Sutton-Spence & Woll, 1999); unrelated sign languages are often mutually 
unintelligible even where two countries share the same spoken language, for 
example, the UK and USA. 
Widely used neuropsychological screening tests such as the Mini Mental State Examination 
(MMSE) (Folstein, Folstein, & McHugh, 1975); the Addenbrookes Cognitive Examination 
Revised (ACE-r) (Mioshi, Dawson, Mitchell, Arnold, & Hodges, 2006) and the Montreal 
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Cognitive Assessment (MoCA) (Nasreddine, Phillips, Bédirian, Charbonneau, Whitehead et 
al., 2005) use language and culture-bound items which do not translate effectively to a sign 
language. Linguistic, cultural and educational differences mean that using interpreters, far 
from being a solution, actually adds unreliability and error to tests (Hill-Briggs, Dial, Morere, 
& Joyce, 2007). Dean and colleagues (2009) evaluated deaf performance on the Mini Mental 
State Examination, which was translated by an interpreter into American Sign Language with 
minimal changes made to items. The mean score for their sample of 117 cognitively healthy 
deaf senior citizens was below the cut-off for normal function, potentially resulting in 
misclassification of cognitive impairment or dementia. Furthermore, use of written 
instructions is inappropriate because prelingually deaf people often have poor 
literacy, with an average reading age of 9 years in the UK (Powers, Gregory, & 
Thoutenhoofd, 1999).  
A further challenge for test translation is heterogeneity among deaf signers. For 
example, there is great variation in: age of acquisition; signing proficiency; and the 
degree to which English influences communication (e.g. in sign order, use of word 
mouthing and fingerspelling, Sutton-Spence & Woll, 1999). Fewer than 5% of deaf 
people have native exposure from Deaf parents (Petitto & Marentette, 1991), and for 
the majority, exposure to sign language is delayed, occurring outside normal 
developmental timeframes, with subtle consequences for grammatical proficiency 
(Cormier, Schembri, Vinson, & Orfanidou, 2012; Marschark, 2003). BSL also has 
wide geographical variation, with substantial lexical differences in older signers from 
different regions of the UK (Stamp, Schembri, Fenlon, Rentelis, Woll et al., 2014). 
Test instructions will need to be understood by signers throughout the UK, with 
different degrees of fluency in BSL, and stimuli needs to be familiar regardless of 
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age or regional background. Simply translating items from an existing test is unlikely 
to meet these demands. 
To overcome these problems we developed a new test administered directly in a 
sign language, titled the British Sign Language Cognitive Screening Test (BSL-CST). 
Crucially the development and norming of the BSL-CST sought to maximise cultural 
and linguistic suitability for the target Deaf population. This was achieved by taking 
an ethnocentric approach, with BSL and Deaf culture as the starting point for the 
generation of new test items and norms rather than attempting a direct translation of 
an existing test or applying existing spoken language norms. The test has no spoken 
or written English language requirement, with video administration wholly in British 
Sign Language. However, to ensure comprehensive screening of the relevant 
cognitive domains, the BSL-CST adopts a similar test structure to ACE-r. It includes 
some items and instructions borrowed from ACE-r and MoCA which were carefully 
modified where necessary for deaf signers and additional novel BSL tasks were 
generated to produce a more accurate picture of function. 
Here we report on the development and reliability of the BSL-CST, taking account of 
the linguistic properties of BSL and the cultural norms of the UK Deaf community. 
We present indicative results with respect to validity and demonstrate the test’s 
usability with a diverse Deaf community. We examine the relationship between 
scores and demographic variables. We provide normative percentiles for clinical use 
and discuss preliminary evidence of diagnostic utility relating to a small clinical group 
of deaf patients with dementia. 
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Methods 
Test procedure  
The British Sign Language Cognitive Screen Test (BSL-CST) was developed by a 
Deaf-led team of neuropsychologists, linguists and a speech and language therapist.  
It is designed for administration in clinical and community settings, with questions 
and instructions presented in BSL video format on a laptop, and taking 30-45 
minutes to complete. The respondent views the video and signs his/her response to 
each test item. The investigator is present during testing and records responses on 
the score sheet. Clarification is provided where instructions are not understood and 
video clips may be repeated. Test sessions are video-recorded to enable scoring to 
be double-checked.  
Test design  
We adapted an existing test framework for sampling cognition but ensured that each 
item was linguistically valid and culturally acceptable to the Deaf community. BSL-
CST structure was modelled on the ACE-R ensuring thorough sampling of each 
cognitive domain: orientation, attention, memory, language, and 
visuospatial/perceptual abilities. Many ACE-R items are unsuitable for assessing 
deaf signers. For this reason, the BSL-CST borrows only six items unchanged from 
the ACE-R with instructions translated into BSL; four ACE-R items are adapted with 
substantial modification to instructions and content; and the remaining nine items are 
completely novel tasks devised directly in BSL. Table 1 shows corresponding ACE-R 
and BSL-CST items and provides details about adaptions, as well as listing 
translated items and the novel alternatives developed for testing BSL memory and 
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language abilities. The BSL-CST extends the scope of the ACE-R by adapting from 
MoCA additional items for vigilance and executive function, with the aim of 
increasing the sensitivity of the test to frontal impairments. Copyright permission was 
obtained from the ACE-R and MoCA research groups for all translations and 
adaptations.  
BSL Video instructions ensured standardised administration, which is impossible to 
achieve using paper-based tests as BSL has no written form. Test instructions were 
recorded onto video by a native Deaf user of BSL, who was from a family with four 
generations of Deaf members and highly familiar with the signing of older Deaf 
people. Filming was a collaborative process involving BSL linguists and 
neuropsychologists. All were native or near-native signers. Three were Deaf and one 
hearing from a Deaf family. The test was designed to be well understood by signers 
across the UK with vocabulary and instructions selected for low regional variability. 
BSL structure and sign order were used, together with clear mouth movements, as 
this is usual for UK signers (Sutton-Spence, 2007), ensuring suitability for a wide 
range of deaf signers, including those who prefer English-influenced varieties of 
signing. Careful piloting and community feedback maximised cultural acceptability to 
the older Deaf Community.  
The maximum BSL-CST score of 110 points is composed of 7 component scores: 
orientation (9 points), attention (11), memory (27), fluency (7), language (39) 
visuospatial/ perceptual (11) and executive function (6). Orientation questions were 
translated from ACE-R with some modifications. One item, ‘What county are we in?’ 
was unreliably correlated to overall score and was removed from the final test. The 
attention component includes fingerspelling words backwards, vigilance for 
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fingerspelled letters and reciting the months of the year backwards in BSL. The 
memory component includes 3-item recalI and immediate, delayed and recognition 
memory for biographical information about a fictional Deaf man, which assesses 
encoding, retrieval and retention. Semantic memory is tested with 4 questions on 
general knowledge. The language section comprises BSL object and picture naming, 
semantic comprehension, sentence production and repetition. Semantic fluency is 
measured by the number of animal signs produced in one minute (fingerspelled 
names were also accepted). Visuospatial and perceptual abilities are screened by 
copying line drawings of a cube and overlapping pentagons, counting dots and 
recognising degraded letters. Executive function overlaps with several of the 
attention, fluency and visuospatial tasks but this component is specifically measured 
by clock drawing and alternating trails, which provide screening of praxis and 
cognitive flexibility. It should be borne in mind that clock drawing is also sensitive to 
visuospatial impairment. Scores for the seven domains can be calculated separately 
and their sum gives the composite BSL-CST score.  
Translated items 
Translated items were mainly limited to visuospatial, perceptual and orientation 
questions where conceptual equivalence could be maintained and cultural translation 
was relatively straightforward. These items were translated into BSL and rigorously 
checked for conceptual equivalence in both languages to ensure preservation of 
psychological integrity. We avoided traditional backtranslation procedures, which 
focus on achieving direct linguistic equivalence between translation and source 
(Crowe Mason, 2005). Instead, we employed a looser definition of backtranslation 
with emphasis on conceptual rather than linguistic correspondence, similar to the 
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ethnographic approach described by Rogers, Young, Lovell, & Evans (2013). This 
was possible because we were not reliant on using existing test norms for hearing 
people but collecting entirely new normative data, so there was no danger of 
translation factors distorting the norms. This procedure followed three stages: Firstly, 
the test development team (all highly bilingual signers) worked collaboratively to 
video record BSL translations of each test item, with an emphasis on obtaining 
conceptual equivalence and retaining psychological integrity. Secondly, two highly 
experienced sign language interpreters individually watched the BSL items and 
translated back to written English. Where differences occurred, a final consensus 
written translation was agreed between them. Thirdly, ten bilingual users of English 
and BSL (Deaf professionals and hearing interpreters) were asked to provide ratings 
of similarity between the original written test items and the written back translated 
versions using a Likert scale (1-7). They were asked to rate the sentences in terms 
of conceptual similarity, a measure of whether the same meaning is conveyed, 
regardless of the words or grammar used. Respondents were asked to use cultural 
knowledge of the differences in the way in which concepts are formed in English 
versus BSL, to inform their ratings. Ratings of conceptual similarity were high 
ranging from 5.33 to 6.75 with a mean of 6.08 (from a maximum of 7) indicating that 
the items had solid conceptual equivalence.  
Novel items 
Tasks were deliberately based on forms of knowledge that have near-universal 
familiarity to the British Deaf community such as the months of the year, 
fingerspelling of the word ‘deaf’ or first names, which are often fingerspelled in 
conversation, and information about the British royal family such as Diana, the 
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former Princess of Wales, who was patron of the British Deaf Association and whose 
life and death was widely followed by British Deaf people. It was important to check 
rather than assume the ability to fingerspell. A culturally appropriate analogue of the 
name and address recall task used in ACE-R was developed by testing memory 
recall and recognition of biographical information about a Deaf man (name, age, 
wife’s name, where he lives and where he went to school). This fits well with Deaf 
culture, as there is social emphasis on establishing such information on meeting a 
new person to discover shared Deaf community connections.  
Novel BSL language tasks were developed to screen BSL naming, production, 
comprehension and sentence repetition. It was a challenge to find objects for naming 
since BSL signs for everyday objects are often highly iconic and depict either their 
visual form or how they are used, and can closely resemble gestures used by 
hearing people (e.g. pen). CANDLE and STRAW were chosen as they elicit low 
frequency signs for which gestures are less easily mistaken. Figure 1 shows the 
twelve picture naming targets used to measure BSL naming. Care was taken to 
ensure that targets could not be easily guessed using a gestural approximation by 
selecting signs which could be represented by a line drawing but had low visual 
iconicity and either intermediate or low familiarity ratings (selected from ratings for 
300 BSL signs in Vinson, Cormier, Denmark, Schembri, & Vigliocco, 2008). Three 
pictures elicited a high number of errors among cognitively healthy signers. Visual 
errors were made for BATTERY and BOMB, and CALENDAR produced semantic 
approximations such as DATE or MONTH. For this reason the picture naming score 
is calculated using only nine of the twelve pictures; however the items were retained 
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for the subsequent comprehension task where the question narrowed down 
response options.  
BSL sentence production was elicited using the picture shown in Figure 2 of a 
woman kissing a man while he washes up. The picture was held up by the examiner 
at shoulder height so that it could only be seen by the respondent. This was to 
encourage a narrative rather than pointing. To obtain a full score of 5 points the 
respondent had to produce two nouns corresponding to both agents and two verbs 
relating their actions in a coherently and syntactically structured utterance.  
BSL sentences for repetition contained some signs selected from the BSL Corpus 
(Schembri, Fenlon, Rentelis, Reynolds, & Cormier, 2013) as exhibiting low regional 
variation. For example BLACK was used in our target sentence as it is one of the few 
colour signs used across the whole of UK, unlike other colour signs which have 
multiple lexical variants which differ across regions and age groups (e.g. PURPLE 
has 22 variants, Stamp et al., 2014). 
Ethics 
The study was approved by the local research ethics committee under Declaration of 
Helsinki guidelines. All participants provided informed consent. Clinical patients 
additionally agreed that anonymised scores collected during routine care could be 
used for research purposes. 
Participants 
Normative data  
Normative data were collected from 226 cognitively-healthy adults aged 50-89 years 
attending holiday camps and social clubs for older deaf people. Participants were 
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sign language users who were born deaf or became deaf before the age of 10 years. 
A screening interview conducted in BSL established suitability for participation. 
Inclusion criteria specified normal or corrected vision and no history of neurological 
disease, brain injury, mental illness, substance abuse or additional disability. The 
only exception was meningitis before 10 years that resulted in deafness. None were 
taking neuroleptic medication and all had refrained from drinking alcohol for 8 hours 
before testing. Table 2 shows demographic information collected through structured 
interview including: age; gender; region; age became deaf; age of BSL acquisition; 
cause of deafness; years of education (from 5 years onwards); occupational status; 
educational attainment; selective school attendance. 
Clinical data 
Recruitment took place at the National Hospital for Neurology and Neurosurgery 
(NHNN), London, where we piloted a monthly cognitive disorders clinic for deaf 
patients using the new tests as part of the diagnostic workup. Patients were 
assessed in the multidisciplinary clinic with a BSL interpreter present. Evaluation of 
cognitive performance on the BSL-CST, and other tests, including the BSL-Verbal 
Learning and Memory test (Denmark, Marshall, Woll & Atkinson, in preparation) and 
Numerical Digit Span were used due to the unavailability of other suitable screening 
tests for deaf signers. Cognitive assessment took place wholly in BSL without an 
interpreter. No diagnosis or detailed clinical information was available when the tests 
were performed as they were completed prior to the clinical consultation. Therefore 
the clinical diagnosis did not interfere with the initial psychological interpretation of 
patient performance. The patient underwent lengthy evaluation, including: history 
from patient and family; neurological examination; MRI; blood dementia screen (as 
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per European guidelines includes: routine haematology – full blood count (FBC), 
erythrocyte sedimentation rate (ESR); routine biochemistry – renal, liver and thyroid 
function, C-reactive protein (CRP); B12/folate, calcium, glucose and lipids; and as 
indicated - antinuclear antibody (ANA), treponemal antibodies and HIV.); and further 
tests as required, such as electroencephalogram and cerebrospinal fluid examination 
for components including tau and a-beta 1-42 proteins, looking for evidence of 
neurodegenerative disease. Consensus diagnosis was reached by a multidisciplinary 
panel including two consultant neurologists, research fellows, specialist nurses, 
neuropsychology and allied disciplines based on standard clinical diagnostic criteria 
for dementia (DSM-IV TR, American Psychiatric Association, 2000) and disease 
specific criteria (e.g. NINCDS-ADRDA McKhann et al., 1984; Dubois, Feldman, 
Jacova, Dekosky, Barberger-Gateau et al., 2007 for AD; Neary, Snowden, 
Gustafson, Passant, Stuss et al, 1998 for FTLD). Diagnosis was based primarily on 
clinical assessment, supported by the results of imaging, neurophysiology, 
immunological tests as well as the BSL-CST results. 
Data for a small group of fourteen patients (seven female) with clinically identified 
dementia are reported. Nine cases were recruited through the Deaf Cognitive 
Disorders Clinic at NHNN and a further five cases were diagnosed within local NHS 
older adult or neurology services following the same gold standard procedure with 
full neuropsychological assessment using the BSL-CST conducted by the same 
clinical psychologist. The group included 11 individuals with a clinical diagnosis of 
Alzheimer’s disease, one frontotemporal dementia, one genetic non AD dementia 
likely to be secondary to mitochondrial disease, and one amnestic mild cognitive 
impairment. Test scores were compared to norms for cognitively healthy deaf people 
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of the same age. Establishing accurate estimates of premorbid function in deaf 
people is difficult. We used WASI Matrix Reasoning (MR), a measure of nonverbal 
intellectual reasoning, with educational and occupational history to screen for 
premorbid intellectual disability, and those with impaired WASI MR scores were only 
included where the participant’s history suggested clear decline from normal 
premorbid function. Table 3 shows demographic information for control and 
dementia groups. 
Measures 
In the norming phase, all participants completed the BSL-Cognitive Screening Test. 
Additionally, Matrix Reasoning (Wechsler Abbreviated Scale of Intelligence, 
Wechsler, 1999) was used to confirm the sample showed normal distribution of 
nonverbal ability and to allow detection of existing impairments in the sample. Two 
measures were used to check how well the BSL-CST correlates with tests of working 
and verbal memory. These were: Numerical Digit Span, a measure of short term and 
working memory with Arabic numerals presented sequentially on a screen for 
immediate recall, in either forward or backward trials, using signed digits as the 
response mode; and the BSL Verbal Memory and Learning Test (Denmark et al., in 
preparation) which requires learning of a list of twelve signs over three trials for 
subsequent recall and recognition.  
Procedure 
Normative data were collected by 13 specially trained, deaf investigators. Videoed 
responses were checked and scored by the second author. The first author also 
independently scored 7.5% of the sample to check for inter-rater reliability (n=17). 
Ten participants (4.4%) were retested 6 months after initial data collection to check 
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test-retest reliability. Retesting focused on younger participants aged 50-59 who 
were expected to show less natural change in cognitive scores over the 6 month 
period. 
 
Analysis 
Normative data were used to establish test validity and reliability as a measure of 
cognitive function in deaf people. The internal consistency of the BSL-CST was 
assessed using Cronbach’s Alpha and Guttman’s split-half coefficient. Inter-rater 
reliability was assessed using intraclass correlation. Cronbach’s Alpha was 
calculated as an indicator of test-retest reliability. Convergent validity between BSL-
CST and other tests of cognition were evaluated using Pearson correlation 
coefficients. 
For the normative sample, descriptive statistics and correlations were computed for 
demographic variables to examine their relationship with test scores. The distribution 
of the whole sample was close to normal. Pearson correlation coefficients were 
calculated for BSL-CST scores and variables including: age; age of BSL acquisition; 
years of education and intellectual ability. Spearman’s rho was calculated for one 
non-normally distributed variable: age of onset of deafness. Differences in BSL-CST 
scores between demographic subgroups including: gender; region; native, early or 
late BSL acquisition; cause of deafness; occupation; academic qualification and 
academically selective school attendance were examined using independent sample 
t-tests and one-way analyses of variance. Percentiles for normative performance 
were generated for clinical comparison. 
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Mann Whitney-U tests were used to examine differences between control and 
dementia groups for: demographic variables; performance on the BSL-CST and 
components. The area under the receiver-operator curve (ROC) was calculated to 
establish the clinical sensitivity and specificity of the test and to determine how 
accurately it distinguishes patients with dementia from controls.  
 
Results 
Reliability and validity  
Inter-rater reliability An intraclass correlation of 0.994 (p<.0001) indicated excellent 
inter-rater reliability, confirmed by the absence of significant disagreement between 
different people scoring the test. 
Test-retest reliability High test-retest reliability for individual items was indicated by 
an intraclass correlation of 0.964. Taking the test score as a whole, there was an 
alpha coefficient of .073 between first and subsequent test scores. Reliability 
increased when semantic fluency was removed from analysis giving .082. Two of ten 
participants’ BSL-CST score improved (M + 3.5 points), five showed a small 
downward change (M -3.4 points), and three remained the same. These findings 
indicate no detectable practice effects, as scores did not consistently improve from 
time 1 to time 2.  
Internal consistency The BSL-CST showed good internal consistency with a 
Guttman split-half reliability coefficient of 0.81 showing that the two halves of the 
tests correlated positively. These comprised pairs of test items measuring the same 
cognitive domain split across the two test halves. A second measure of consistency 
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examined the contribution of each component score (e.g. memory, language etc.) to 
the overall test score. A Cronbach’s Alpha of 0.74 indicated an acceptable level of 
correlation between components, showing that each contributes to the latent variable 
of cognition but also adds unique information and none was superfluous to the 
overall objective of thoroughly screening cognition. 
 
Content validity  It was not possible to provide a measure of convergent validity with 
another multi-domain cognitive screening test because the BSL-CST is the first tool 
of its kind so there is no gold standard against which to compare. However, scores 
did correlate with other, more detailed measures of short term memory, working 
memory, verbal learning, executive function and sentence repetition, which are 
sensitive to cognitive decline and ageing. Effect sizes (ES) using Cohen’s standards 
are reported in brackets. Data for the whole sample on the BSL-CST correlated with 
forward digit span r(219)=0.325, p<.001 (medium); backward digit span, 
r(220)=0.557, p<.001 (large); and showed weaker correlation with sums of trials 
score on the BSL-Verbal Learning and Memory Test r(222)=-0.15, p<.05 (small). 
Further evidence comes from a subgroup of 52 participants (37 female, age 50-89, 
M 67.87, SD 10.38) who also completed tests of executive function and BSL 
sentence repetition one year later as part of another study. All executive function 
scores correlated with BSL-CST performance, including: measures of cognitive 
flexibility (Colour Trails Test, D’Elia, Satz, Uchiyana, & T, 1996, r=-0.643, p=<.001, 
large ES); number of errors on the Nelson Modified Card Sorting Task, Nelson, 
1976, r=-.554, p=<.001, large ES); planning (DKefs Tower of LondonDelis, Kaplan, & 
Kramer, 2001, r=0.523, p=<.001, large ES); processing speed/ attention (WAISIII 
Symbol Search, Wechsler, 1997, r=0.402, p=<.01, medium ES) and cognitive fluency 
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(DKefs Design Fluency, Delis, Kaplan, & Kramer, 2001, r=0.572, p=<.001, large ES), 
Letter F fluency, (r=0.470, p=<.001, medium ES). BSL sentence repetition, a 
language measure which taps BSL fluency and working memory, also weakly 
correlated with the BSL-CST (r=0.351, p=<.05, medium ES). Taken collectively these 
correlations show that there is a robust relationship among cognitively healthy 
controls between performance on the BSL-CST and tests of a wide range of 
cognitive abilities, exactly what would be hoped for from a cognitive screening tool. 
While not conclusive these findings suggest the test has content validity.  
Suitability for a diverse Deaf community 
It is important that the BSL-CST is able to accurately measure cognition in a diverse 
Deaf community. It has no ceiling or floor effects, with scores ranging from 56-108 
out of a possible 110 points (M 92.79, SD 9.70), suggesting suitability for use across 
age and intellectual spectrums. Table 2 shows the statistical relationships between 
demographic variables and test scores, indicating the test was well understood by 
signers from all UK regions, with no significant difference in distribution of test scores 
between signers who shared the regional dialect of the video presenter (South 
Eastern England) and those from other regions. Likewise, there was no statistical 
difference between users of BSL and those who preferred more English-influenced 
forms of signing. There was no significant effect of gender, cause of deafness, age 
of onset, or age of BSL acquisition, suggesting that the test is a suitable instrument 
for use across a heterogeneous Deaf community. 
Relationship with demographic variables 
Table 2 shows correlations between test scores and demographic variables. BSL-
CST is sensitive to ageing, with scores correlating negatively to age, demonstrating 
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a decrease in mean performance among older participants, as shown in the 
scattergraph in Figure 3. Number of years of education, occupational status, 
educational attainment (highest qualification) and selective schooling (determined by 
exams taken at 10-11 years old), are all positively related to test scores. It is 
important to consider the possible effect of age on these correlations because 
different schooling regimes were experienced by different age groups in our study 
with older participants typically leaving school earlier r(225)=.352, p<.001 and with 
fewer qualifications F(5,200)=10.784, p<.001. There were no significant differences 
in age among occupational status groups F(4,221)=.962, p=42.9, or between those 
who had attended academically selective schools and those who had not 
t(221)=.380, p=.704. There was a medium-sized positive correlation of BSL-CST 
scores and years of education after controlling for the effects of age using partial 
correlation r(222)=.241, p<.001. Higher nonverbal intellectual ability, measured by 
age-adjusted scores on WASI Matrix Reasoning, was associated with better BSL-
CST performance as shown in the scattergraph in Figure 4. 
Normative data for clinical use 
Mean test score and standard deviation for each age group are presented in Table 2. 
Percentile age bands are presented in Table 4 enabling clinicians to compare 
obtained scores to the normative range for the patient’s age group. Further data is 
presented in Table 5 to allow clinicians to cross reference patient scores with 
subgroups of signers of similar age and length of education. This is important 
because it is difficult to estimate premorbid intelligence in deaf signers using 
conventional methods. A cut between more or less than 12 years of education (from 
the age of 5 onward) was identified as clinically useful because there was a 
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significant difference in BSL-CST scores for these two groups (t(222)=-5.20, p<.001) 
and a large effect size (d=0.883). There was no statistical difference between more 
finely grained years of education groups.  
Age of BSL acquisition is not built into percentile tables because differences in test 
scores did not reach significance for native, early (1-5 years) and late (6+ years) 
groups, although this information is still clinically relevant. Figure 5 shows native 
signers had higher mean scores and a lower standard deviation than those born into 
hearing families who acquired BSL in infancy or after the age of 6 years. 
Clinical data 
The distribution of patient scores can be seen on the scattergraph shown in Figure 3. 
Dementia scores are lower than control scores with the exception of five normative 
outliers who achieved a score of 70 or less. All except three of the dementia group 
were aged between 70-89 years, differing significantly in age from the normative 
sample, which ranged from 50-89 years. For this reason we used Mann-Whitney U 
tests to compare: demographics; BSL-CST composite and component scores, of the 
11 people with dementia aged 70-89 years, to a subgroup of 99 controls who were 
also aged 70-89 years. Results on Table 6 show that these groups were well 
matched demographically with no significant differences in age, years of education 
or age of BSL acquisition. Statistical comparison of composite and component 
scores indicate that the BSL-CST has validity as a cognitive screening instrument 
because patients achieve a consistently lower distribution of scores than controls for 
overall cognitive function and within each cognitive domain (e.g. memory, language 
etc.). Mann-Whitney U findings led to the rejection of the null hypothesis that 
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distribution of BSL-CST composite and component scores are the same across 
healthy and patient groups. 
A Receiver Operating Characteristic (ROC) curve is a useful way to interpret the 
diagnostic utility of the BSL-CST. The area under the curve (AUC) indicates the 
ability of the screening measure to reliably distinguish between patients with 
dementia and controls. A ROC curve was calculated using BSL-CST scores for the 
whole sample of dementia (n=14) and control (n=226) participants (Figure 6). The 
AUC for the BSL-CST is 0.996 (99.6%, P<.001, 95% CI=0.99 to 1.00) which, 
applying a rule of thumb of >.9, indicates an excellent trade-off between sensitivity 
and specificity, meaning that there is an extremely high true positive rate with 
patients correctly classified as belonging to the dementia group and a low false 
positive rate, with very few controls erroneously classified as having dementia. Our 
AUC value is close to 1, indicating highly reliable clinical accuracy, whereas a value 
of .50 would indicate the predictor is no better than chance (Zhou & Obuchowski, 
Obushcowski, 2002). The ROC curve can be used to determine a cut off score for 
dementia screening, below which there is a very high chance that a person has 
dementia or another cognitive disorder. Examining the sensitivity and specificity for 
each possible total suggests that a score of 71 can be identified as a likely cut-off. 
Based on the current sample this gives a sensitivity of 100% correct classification of 
dementia patients and misclassifies only 2.2% (n=5) of controls as belonging to the 
dementia group. Table 7 shows that a lower cut-off point would increase false 
negatives, wrongly classifying dementia patients as being cognitive healthy; and a 
higher cut-off point would increase false labelling of controls as having dementia.  
Relationship between BSL-CST and nonverbal intellectual ability 
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We investigated how well the BSL-CST was able to distinguish between control 
participants with low intellectual ability and those with cognitive decline. We used 
WASI Matrix Reasoning (MR) as an indicator, because of its reliability as a global 
measure of nonverbal ability when used with deaf people, although we acknowledge 
that using a single measure may miss; or be specifically sensitive to, more focal 
impairments. Figure 4 shows obtained scores plotted against BSL-CST scores. 
Twenty-five control participants had borderline scores, and two were impaired, 
meaning that 11.9% of the normative sample fell outside the normal range for 
nonverbal intellectual ability (n=27). Only 3 of this group were also BSL-CST outliers, 
with scores that fell below the suggested cut off score for identifying those with 
dementia. The remaining 22 low ability participants achieved BSL-CST scores that 
do not flag up risk of dementia. This pattern of low WASI MR paired with unimpaired 
BSL-CST score suggests developmental rather than acquired cognitive impairment 
in this group.  For the majority of cases in our sample the BSL-CST was able to 
distinguish those with low intellectual ability from those who have dementia, meaning 
that this instrument may have utility as a screen even when premorbid borderline 
intellectual impairment is present, and conversely demonstrates that the BSL-CST 
should not be used to screen for learning disability in deaf people. Figure 4 shows 
that the typical pattern for the dementia group is different, combining a BSL-CST 
score below 71 with normal range scores on WASI MR. This was true for 9 out of 13 
dementia patients (69.2%). Four individuals with dementia had borderline (n=2) or 
impaired (n=2) nonverbal intellectual ability. These findings fit with research that has 
shown that although WASI MR shows some decline in dementia patients, it shows 
resilience compared to other measures, at least until late stages of the disease 
(Ryan, Carruthers, Miller, Souheaver, Gontkovsky et al., 2005), unless visuospatial 
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cognition is compromised, though there have been no studies examining this in deaf 
populations. Of the five outliers misclassified as having dementia due to low BSL-
CST scores, two fit the profile of acquired cognitive impairment, and a further three 
are impaired on both the BSL-CST and WASI Matrix Reasoning, indicating either 
developmental or acquired cognitive disability.  
 
Discussion  
As the proportion of older people in the Deaf community increases, there is greater 
need for sensitive diagnostic screens to detect change indicative of incipient 
dementia, secondary to neurodegeneration. The BSL-CST shows validity as a 
cognitive screen across a wide demographic of deaf people who use sign language 
to communicate. Feedback indicated that rapport was not negatively affected by 
video instructions. BSL-CST sampling replicates screening tools for the general 
population, which are considered to have good content validity (Freitas, Simões, 
Marôco, Alves, & Santana, 2012; Law, Connelly, Randall, McNeill, Fox et al., 2013). 
It shows good reliability with high internal consistency, with all component scores 
contributing to and correlating with the overall test score, which in turn reliably 
indicates the presence or absence of dementia, and good stability, with high test-
retest reliability and low practice effects. Healthy signers show fluctuations of +/- 3 
points on retest so this needs to be borne in mind when using the test to track 
change in patients over time.  
Evaluation of clinical potential  
Tentative analysis based on 14 cases suggests the BSL-CST has good construct 
validity for measuring cognitive impairment and diagnosing Alzheimer’s disease. It 
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had high sensitivity and specificity as indicated by the excellent AUC, detecting 
dementia in all patients tested and misclassifying only five controls, who are likely to 
have either developmental or acquired cognitive impairments or possibly, dementia.  
The lack of previously validated tests for supporting dementia diagnosis in deaf 
people is a problem for the current methodology because the test under evaluation 
was also used to support diagnosis of clinical participants giving rise to issues of 
circularity. Diagnosis did not rest critically on the results of these tests, though they 
were used as one element of support. Clinical observation and assessment, 
describing patterns of cognitive symptoms, and tempo and quality of decline, 
provided the fundamental basis for clinical diagnosis, which was refined using 
multimodality investigation and multidisciplinary review. We feel this minimised the 
impact of circularity. With this reservation in mind, the BSL-CST showed good 
clinical potential. 
Limitations 
Late diagnosis of dementia in our sample may explain why the AUC is so high, as 
our dementia sample is distinctly impaired relative to controls. Deaf patients had 
experienced long delays in accessing appropriate diagnostic assessment, typically 
showing symptoms for at least 2 years, prior to arriving at the specialist clinic, 
therefore their dementia was more advanced than might be seen in a clinical sample 
taken from the general hearing population. As access to services and awareness of 
dementia within the Deaf community improves, we expect that people will present at 
an earlier stage . It would be useful to repeat these analyses with participants 
showing milder levels of cognitive impairment to further assess test sensitivity.  
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It is likely that, despite pre-screening, our sample contained cases of undiagnosed 
learning disability or acquired cognitive impairment. We checked distribution of 
nonverbal intellectual ability (WASI Matrix Reasoning scores) and found moderate 
skew towards low ability (skewness -.428) for the whole group. Further breakdown 
by age showed that participants in their 70s and 80s showed expected distribution of 
ability but there was a non-normal, bimodal distribution for those in their 50s and 
60s, suggesting that the younger bands included two different populations of deaf 
people, with one group having with low intellectual ability. Eighteen individuals (14% 
of those in these two age groups) fell in the borderline to severely impaired range.  
Predisposing risk factors among deaf people include organic causes of deafness that 
may also cause intellectual disability, such as: prematurity (Peterson, 2000), 
meningitis (Anderson, Anderson, Grimwood, & Nolan, 2004; Grimwood, Anderson, 
Anderson, Tan, & Nolan, 2000), maternal rubella or cytomegalovirus infection (CMV) 
during prenatal development (Takano, Morimoto, Bamba, Takeuchi, & Ohno, 2006), 
and unidentified or poorly treated circulatory disorders which may adversely impact 
cognition in older adults (Sign Health, 2014). There may also be selection bias in our 
holiday camp sample because high ability, economically active deaf signers of 
working age in their 50s and 60s might be expected to be less attracted to a holiday 
targeted at older people. These factors make it clear that the Deaf population may 
include individuals with hidden cognitive impairments, showing need for better 
service provision and diagnostic tests like the BSL-CST. It is noteworthy that despite 
the presence of these outliers, our normative and dementia groups are distinct and 
the BSL-CST provides excellent discrimination for clinical purposes.  
Applications of the BSL-CST 
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The sampling and distribution issues should be taken into account when interpreting 
BSL-CST results particularly for those aged 50-69 years. Where a score falls below 
the 1st- 2nd percentile, confidence of clinical impairment can be increased, but the 
test may underestimate cognitive impairment in a deaf person with high premorbid 
ability. 
We urge caution in the clinical use of a tentative cut-off score of 71 for distinguishing 
between dementia patients and controls based on the data in this study, because of 
the very small dementia group size and lack of data for patients diagnosed with mild 
cognitive impairment (MCI). The cut-off should only be used as a guide, and always 
with reference to normative percentiles, until further validation is done with a much 
larger sample. This reinforces the need to only use BSL-CST to support dementia 
diagnoses in conjunction with thorough history taking, imaging and medical tests. 
The BSL-CST is intended to be a screening tool and should not substitute detailed 
assessment. Where BSL-CST scores indicate concern; or an individual has high 
premorbid function; or complains of problems that are not identified by this basic 
screen, the patient should always be assessed using additional, in-depth tests for 
each cognitive domain. For example, the BSL Verbal Learning and Memory Test 
(Denmark et al., in preparation) can be used to provide a more fine-grained 
assessment of verbal memory and learning. 
Future research  
More extensive clinical evaluation of diagnostic utility with a bigger patient sample is 
essential. This would enable the determination of clinical cut-off values for MCI and 
dementia; the development of severity ratings; the usefulness of individual domain 
scores; and ratios which may assist differential diagnosis between Alzheimer’s 
disease and other types of dementia, allowing different cognitive profiles associated 
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with different causes of neurodegeneration to emerge. The relationship between test 
scores and biological markers could be established, with the aim of facilitating the 
earliest possible diagnosis for deaf patients, so as clinical care improves they will be 
able to access new developments in preventative pharmacology.  
Further research is required to validate the use of the BSL-CST by clinicians who 
have no knowledge of sign language, and who use a BSL-English interpreter, the 
administration of the BSL-CST by trained Deaf clinical technicians, or its use where a 
signing clinician is remotely located using telemedicine. Although questions and 
instructions are recorded on video, BSL-CST administration still requires high 
proficiency in BSL to clarify and repeat instructions, and to understand and record 
the client’s signed responses. It is not yet known whether additional cognitive 
demands would be placed on a deaf respondent having to share attention between 
the video, clinician and interpreter, and how this might affect scores, potentially 
leading to departure from normative scores, which were collected directly in BSL. 
Patient and carer rating scales using BSL also need to be developed, to measure 
adaptive behaviour and activities of daily living for use in conjunction with the BSL-
CST. 
International use 
Just as tests like ACE- and MoCA have international application and have been 
translated into many different spoken languages, the BSL-CST has the potential to 
be the basis for cognitive screening tools in signed languages around the world. 
Although, our measure employs British Sign Language, used in the UK, with variants 
in Australia and New Zealand, the format and method are suitable for adaptation into 
other signed languages, with potential for transforming early diagnosis of cognitive 
disorders and dementia in deaf signers in other countries. Items will need to be 
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carefully modified to ensure good cultural and linguistic fit to each national Deaf 
community.  
 
Conclusion 
Developing tests directly in sign language rather than relying on translation is 
imperative for clinical accuracy and for profiling patterns of cognition and impairment 
in deaf people, which would be overlooked or miss-measured using spoken 
language frameworks. Tests like the BSL-CST will be essential tools in the push for 
earlier diagnosis in deaf people who use signed languages. The instrument reported 
in this paper is a good starting point, but it requires parallel initiatives to tackle the 
barriers preventing equal access to health care services, with a global need for 
improved availability of clinical specialists with expertise in Deaf culture and signed 
languages. 
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Tables 
 ACE-R item Score BSL-CST item Score Source Modifications/Justification 
O
rie
n
ta
tio
n
 
Orientation to time: 
day, date month, year, 
season 
Orientation to place: 
building, floor, town, 
country, county 
5 
 
 
5 
Day, date month, year, season 
 
 
Building, floor, town, country 
5 
 
 
4 
Translated from 
ACE-r 
Seasons were listed 
 
 
County was removed due high error rate 
A
tte
n
tio
n
 
 Serial 7s  
Spell WORLD 
backwards 
5 
(higher 
score 
of the 
two 
tasks) 
Fingerspell DEAF backwards.  
Fingerspell the name CHRIS 
backwards 
4 
5 
Novel DEAF selected as universally known spelling. 
Names are usually fingerspelled in BSL giving 
ecological validity. Ability to spell forwards 
was checked 
- - Tapping task: tap the table when you 
see the fingerspelled letter ‘A’ 
1 Adapted from 
MoCA 
Letter stimuli were fingerspelled rather than 
spoken 
- - Months of the year backwards 1 Novel Months of year are universally familiar to UK 
signers 
M
e
m
o
ry
 
Memory immediate 
and delayed recall: 
LEMON, KEY, BALL 
6 Memory immediate and delayed recall: 
BALL, TREE, PEN 
6 Adapted from  
ACE-r 
Signs used have low regional variability and 
historic change 
Name and address 
 
Immediate (3 trials) 
Delayed 
Recognition 
 
 
7 
7 
6 
Learning novel information about a 
Deaf man (name, age, wife’s name, 
where lives and school attended).  
Immediate recall (3 trials) 
Delayed 
Recognition 
 
 
 
6 
6 
5 
Novel Culturally appropriate memory screen using 
biographical information about a Deaf man, 
rather than a written name and address 
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Anterograde and 
retrograde memory: 
Name of current prime 
minister, Name of 
former woman prime 
minister, Name of USA 
president, Name of 
USA president who 
was assassinated in 
1960s 
4 Name of current prime minister, Name 
of former woman prime minister 
 
First name of the Queen, Name of 
royal who died in a car crash 
4 Translated from 
ACE-r 
 
Novel  
Retrograde memory question about historic 
figure well known in the Deaf community, 
Princess Diana (Former patron of British Deaf 
Association) 
V
e
rb
a
l 
flu
e
n
c
y
 
 Verbal fluency  
Letter 
7 - - - Not used due to reliance on English 
vocabulary 
Verbal fluency  
Animals 
7 Semantic Sign fluency for animals 7 Adapted from 
ACE-r 
Instructions are modified using example of 
fluency for food 
L
a
n
g
u
a
g
e
 
L
a
n
g
u
a
g
e
 
Language 
comprehension: 
Written instruction 
‘Close your eyes’ 
1 - - - Not used due to reliance on written English 
Comprehension 
Three stage 
command: ‘Take the 
paper in your right 
hand. Fold in half. 
Put the paper on the 
floor’ 
3 BSL three stage command: ‘Take the 
paper in your right hand’. Fold in half. 
Put the paper on your lap’ 
3 Adapted from 
ACE-r 
Put on your lap’ was substituted for ‘Put on 
the floor’ to make it more suitable for testing 
infirm patients.  
In the translated version the signs used 
model the precise actions required and which 
hand to use. This means that impaired 
performance is more significant. 
Sentence production 
‘Write a sentence’ 
(must contain subject 
and verb) 
1  BSL Sentence production: ‘Look at 
picture. There are two people, tell me 
what they are doing?’ Response 
must contain; 2 nouns 2 verbs and 
be a coherent sentence 
5 Novel The picture was carefully selected to show 
two people interacting while performing two 
different actions, encouraging production of 
sentences with 2 nouns and 2 verbs.  
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Word repetition: 
hippopotamus, 
eccentricity, 
unintelligible, 
statistician 
2 - - - Not used due to reliance on spoken English. 
Signs are not multisyllabic so there is no 
equivalent measure 
Sentence repetition 1 BSL sentence repetition  15 Novel Scoring acknowledges flexibility in word 
order allowed by BSL grammar 
Object naming 
Pencil, watch 
2 BSL object naming 
straw, candle 
2 Novel The signs for ‘pencil’ and ‘watch’ are similar 
to their gestural form, so these were replaced 
with objects eliciting low frequency signs for 
which gestures are less easily mistaken. 
Picture naming  10 BSL picture naming:  9 Novel BSL naming task elicits signs with low 
iconicity and familiarity ratings to ensure that 
targets cannot be guessed due to visual 
iconicity or gesturability 
Language 
comprehension 
questions 
4 BSL Language comprehension 
questions 
5 Novel Novel questions related to the picture naming 
items. Participants respond by pointing to the 
correct picture.  
 Reading irregular 
words 
1 - - - Not used due to reliance on written English 
V
is
u
o
s
p
a
tia
l 
Copy overlapping 
pentagons 
1 Copy wire cube 1 Translated from 
ACE-r 
No modifications 
Copy wire cube 2 Copy wire cube 2 Translated from 
ACE-r 
No modifications 
Perceptual abilities 
Count the dots 
4 Count the dots  4 Translated from 
ACE-r 
No modifications 
Perceptual abilities: 
Identify degraded 
letters 
4 Identify degraded letters  4 Translated from 
ACE-r 
No modifications 
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E
x
e
c
u
tiv
e
 fu
n
c
tio
n
 
Clock drawing: ‘Draw a 
clock face with 
numbers and hands at 
ten past five’ 
5 Clock drawing: ‘Draw a clock with 
numbers and hands to show the time 
at 1:45’ 
5 Adapted from 
ACE-r 
1:45 was used in preference to ten past five 
because in BSL the latter gives greater clue 
to the correct placement of clock hands. We 
subsequently decided to sign 1:45 in a 
spatially neutral way as ONE POINT FORTY 
FIVE.  
- - Alternating trails: Draw a line 
alternating between numbers and 
letters. 
1 Translated from 
MoCA 
Additional reinforcement of instructions.  
 Total score ACE-R 100 Total BSL-CST 110 
S
u
b
c
o
m
p
o
n
e
n
ts
 
Attention & 
Orientation /18 
Memory /26 
Fluency /14 
Language /26 
Visuospatial /16 
 Orientation /9 
Attention /11 
Memory /27 
Fluency /7 
Language /39 
Visuospatial/perceptual /11 
Executive function /6 
 
Table 1shows ACE-R and BSL-CST items, domains, subcomponents and provides details about translated, adapted and novel items 
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Table 2 Demographic variables, mean BSL-CST scores, standard deviations and statistical values 
Variable N=226 Percent  M (SD) r/rs /F/t 
Age    92.79 (9.70) 
r(224)=-0.430 
p=<0.001* 
50-59 51 22.6 97.41 (8.26) F(39,186)=2.078 
p<0.001* 
d=3.305* 
60-69 76 33.6 95.16 (9.72) 
 
70-79 50 22.1 89.60 (8.72) 
 
80-89 49 21.7 87.55 (8.62) 
 
Gender     
Female 144 63.7 91.24 (10.18) t(224)=-1.815 
p=0.71 
Male 82 36.3 93.67 (9.34) 
 
Region     
South East England 105 46.5 92.66 (9.70) t(223)=-0.225 
p=0.822 
Other UK regions  120 53.1 92.95 (9.76) 
 
Age became deaf    rs(224)=-0.071 
p=0.289 
     
Age of BSL acquisition    r(224)=-0.038 
p=0.573 
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Native 27 11.9 97.74 (12.06) F(39,184)=1.083 
p=0.354 
Early (1-5 yrs) 92 40.7 92.42 (8.63) 
 
Late (6+ yrs) 105 46.4 91.79 (9.67) 
 
Cause of deafness     
Genetic 72 31.9 95.51 (9.37) F(39,182)=1.464 
p=0.051 
Organic  48 21.2 92.19 (7.98) 
 
Other/unknown 102 45.1 91.05 (10.25) 
 
Years of education (from 5 yrs)    
r(224)=0.365 
p=<0.001* 
7-9 32 14.2 89.28 (11.11) F(4, 220)=8.401 
p=<0.001* 
d=3.743* 
10-12 149 65.9 91.59 (9.36) 
 
13-14 24 10.6 96.79 (7.50) 
 
15-16 14 6.2 101.71 (2.55) 
 
17-21 5 2.2 104.60 (4.93) 
 
Occupational status     
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Professional 7 3.1 103.14 (7.22) F(39, 186)= 
1.698 p=<0.01*  
d=3.634* 
Intermediate 7 3.1 102.14 (4.18) 
 
Skilled 79 35.0 94.23 (8.51) 
 
Semi-skilled 76 33.6 91.78 (9.48) 
 
Unskilled 57 25.2 89.72 (10.54) 
 
Educational attainment     
Degree/postgraduate 11 4.9 104.45 (3.67) F(39,186)=3.021 
p=<0.001* 
d=4.504* 
A level or equivalent 4 1.8 103.00 (4.24) 
 
O level/CSE/GCSE or equivalent 13 5.8 98.46 (6.92) 
 
BSL teaching 13 5.8 98.46 (8.45) 
 
Vocational 43 19.0 96.23 (9.16) 
 
None 142 62.8 89.51 (8.93) 
 
 Attended selective school      
Yes 17 7.5 99.82 (5.16) t(26.81)=5.363 
p=<0.001* 
d=0.799 
No 206 91.2 92.17 (9.83) 
 
*Asterisk marks significant results or large effect size 
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Table 3 Demographics for control and dementia groups  
 Control N=226  
 
Dementia N=14  
 
Mann 
Whitney 
U 
 M SD Min-Max M SD Min-
Max 
 
Age 68.26  10.24 50-89 76.93 9.53 54-83 ‡ 
Years of education 11.38  2.11 4-20.5 10.77 0.68 9-11.5  
Age of BSL 
acquisition 
6.39 5.11 0-40 5.14 2.65 0-11  
BSL-CST scores 
(Max. score 110) 
92.79  9.70 56-108 54.00 9.35 43-71 † 
†p<0.001, ‡p<0.01 (Mann-Whitney U test, two-tailed) 
 
Table 4 Age band percentile scores for BSL-CST  
Age band 
(years) 
Percentile scores  
 1st - 2nd 5th 10th 25th 50th  75th  90th 
50-59 77 79.2 82.2 92 101 103 107.4 
60-69 73 
*outliers 
removed 
77 83.1 91 97 102.8 107 
70-79 66 71.7 79 84 90 96.5 102.5 
80-89 65 72.5 76 80.5 89 95.5 99.5 
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Table 5 Mean scores and standard deviations for age bands and years of education groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Years of education is measured from 5 years onwards.  
2 cases with missing years of education information 
  Years of Education 
Whole sample  All <=12 >12 
N 226 181 43 
M 92.79 91.18 99.30 
SD 9.70 9.70 6.64 
50-59 yrs All <=12 >12 
N 51 35 16 
M 97.41 95.37 101.88 
SD 8.26 8.54 5.58 
60-69 yrs All <=12 >12 
N 76 56 19 
M 95.16 93.80 98.79 
SD 9.72 10.38 6.55 
70-79 yrs All <=12 >12 
N 50 45 5 
M 89.60 89.07 94.40 
SD 8.72 8.58 9.45 
80-89 yrs All <=12 >12 
N 49 45 3 
M 87.55 86.78 97.00 
SD 8.62 8.56 1.73 
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Table 6 Comparison of control and dementia groups aged 70-89 years on 
demographics, BSL-CST score and subcomponents 
 Control N=99  Dementia N=11  Mann 
Whitney U 
 M SD Min-Max M SD Min-
Max 
 
Age 78.0      5.73   70-89    80.82 5.38 73-88  
Years of education 10.60 1.48 7-15.5 10.69 0.80 9-11.5  
Age of BSL 
acquisition 
6.58 5.15 0-40 5.09 1.81 2-9  
BSL-CST score  
(Max. score 110) 
88.59 8.69 65-105 51.91 8.79 43-71 † 
Orientation (9) 7.91 1.03 5-9 3.91 1.37 1-5 † 
Attention (11) 8.66 2.29 1-11 3.64 3.67 0-10 † 
Memory (27) 22.73 3.64 12-27 10.36 5.39 2-21 † 
Fluency (7) 4.42 1.71 1-7 1.64 1.43 0-4 † 
Language (39) 31.15 3.42 22-38 21.36 4.37 15-27 † 
Visuospatial/ 
perceptual (11) 
10.00 1.15 6-11 8.73 1.35 7-11 ‡ 
‡ 
Executive function 
(6) 
3.71 1.53 0-6 2.27 1.35 0-5  
†p<0.001, ‡p<0.01 (Mann-Whitney U test, two-tailed) 
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Table 7 Sensitivity-specificity trade-offs of different cut scores on the BSL-CST 
 
BSL-CST Sensitivity Specificity 
<68 0.86 0.982 
<70 0.86 0.978 
<71 1.00 0.978 
<72 
<74 
<76 
1.00 
1.00 
1.00  
0.973 
0.965 
0.956 
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Figure legends 
Figure 1 BSL-CST picture naming 
Figure 2 Target picture for BSL sentence production 
Figure 3 Scattergraph showing BSL-CST scores and best fit lines for control and 
dementia groups  
Figure 4 Scattergraph showing BSL-CST scores and WASI Matrix Reasoning t 
scores for control and dementia groups  
Figure 5 Boxplot showing mean BSL-CST scores and standard deviations of age of 
BSL acquisition groups in normative sample (n=226) 
Figure 6 Receiver Operating Characteristic curve for BSL-CST composite score 
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Figure 5 
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Figure 6 
 
 
 
 
 
 
